{"pmid":32278716,"title":"The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic.","text":["The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic.","Patients with structural heart disease (SHD) are at increased risk of adverse outcomes from the coronavirus disease 19 (COVID-19) due to advanced age and comorbidity. In the midst of a global pandemic of a novel infectious disease, reality-based considerations comprise an important starting point for formulating clinical management pathways. The aim of these \"crisis-driven\" recommendations is (1) to ensure appropriate and timely treatment of SHD patients, (2) to minimize the risk of COVID-19 exposure to patients and healthcare workers, and (3) to limit resource utilization under conditions of constraint. While the degree of disruption to usual practice will vary across the United States and elsewhere, we hope that early experiences from a Heart Team operating in the current global epicenter of COVID-19 may prove useful for others adapting their practice in advance of local surges of COVID-19.","J Am Coll Cardiol","Chung, Christine J","Nazif, Tamim M","Wolbinski, Mariusz","Hakemi, Emad","Lebehn, Mark","Brandwein, Russell","Rezende, Carolina Pinheiro","Doolittle, James","Rabbani, Leroy","Uriel, Nir","Schwartz, Allan","Biviano, Angelo","Wan, Elaine","Hathaway, Lisa","Hahn, Rebecca","Khalique, Omar","Hamid, Nadira","Ng, Vivian","Patel, Amisha","Vahl, Torsten","Kirtane, Ajay","Bapat, Vinayak","George, Isaac","Leon, Martin B","Kodali, Susheel K","32278716"],"abstract":["Patients with structural heart disease (SHD) are at increased risk of adverse outcomes from the coronavirus disease 19 (COVID-19) due to advanced age and comorbidity. In the midst of a global pandemic of a novel infectious disease, reality-based considerations comprise an important starting point for formulating clinical management pathways. The aim of these \"crisis-driven\" recommendations is (1) to ensure appropriate and timely treatment of SHD patients, (2) to minimize the risk of COVID-19 exposure to patients and healthcare workers, and (3) to limit resource utilization under conditions of constraint. While the degree of disruption to usual practice will vary across the United States and elsewhere, we hope that early experiences from a Heart Team operating in the current global epicenter of COVID-19 may prove useful for others adapting their practice in advance of local surges of COVID-19."],"journal":"J Am Coll Cardiol","authors":["Chung, Christine J","Nazif, Tamim M","Wolbinski, Mariusz","Hakemi, Emad","Lebehn, Mark","Brandwein, Russell","Rezende, Carolina Pinheiro","Doolittle, James","Rabbani, Leroy","Uriel, Nir","Schwartz, Allan","Biviano, Angelo","Wan, Elaine","Hathaway, Lisa","Hahn, Rebecca","Khalique, Omar","Hamid, Nadira","Ng, Vivian","Patel, Amisha","Vahl, Torsten","Kirtane, Ajay","Bapat, Vinayak","George, Isaac","Leon, Martin B","Kodali, Susheel K"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278716","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jacc.2020.04.009","keywords":["Covid-19","Heart Team","Valve Center","s: Structural Heart Disease"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1663890922007429121,"score":7.9164424,"similar":[{"pmid":32250751,"title":"Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","text":["Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.","JACC Cardiovasc Interv","Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif","32250751"],"abstract":["The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic."],"journal":"JACC Cardiovasc Interv","authors":["Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250751","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jcin.2020.04.001","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352136289746944,"score":322.87457},{"pmid":32251546,"title":"Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","text":["Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif","32251546"],"abstract":["The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251546","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ccd.28910","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352136298135552,"score":316.74677},{"pmid":32255413,"title":"The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","text":["The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19.","Radiology","Rubin, Geoffrey D","Haramati, Linda B","Kanne, Jeffrey P","Schluger, Neil W","Yim, Jae-Joon","Anderson, Deverick J","Altes, Talissa","Desai, Sujal R","Goo, Jin Mo","Inoue, Yoshikazu","Luo, Fengming","Prokop, Mathias","Richeldi, Luca","Tomiyama, Noriyuki","Leung, Ann N","Ryerson, Christopher J","Sverzellati, Nicola","Raoof, Suhail","Volpi, Annalisa","Martin, Ian B K","Kong, Christina","Bush, Andrew","Goldin, Jonathan","Humbert, Marc","Kauczor, Hans-Ulrich","Mazzone, Peter J","Remy-Jardin, Martine","Schaefer-Prokop, Cornelia M","Wells, Athol U","32255413"],"abstract":["With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19."],"journal":"Radiology","authors":["Rubin, Geoffrey D","Haramati, Linda B","Kanne, Jeffrey P","Schluger, Neil W","Yim, Jae-Joon","Anderson, Deverick J","Altes, Talissa","Desai, Sujal R","Goo, Jin Mo","Inoue, Yoshikazu","Luo, Fengming","Prokop, Mathias","Richeldi, Luca","Tomiyama, Noriyuki","Leung, Ann N","Ryerson, Christopher J","Sverzellati, Nicola","Raoof, Suhail","Volpi, Annalisa","Martin, Ian B K","Kong, Christina","Bush, Andrew","Goldin, Jonathan","Humbert, Marc","Kauczor, Hans-Ulrich","Mazzone, Peter J","Remy-Jardin, Martine","Schaefer-Prokop, Cornelia M","Wells, Athol U"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255413","week":"202015|Apr 06 - Apr 12","doi":"10.1148/radiol.2020201365","source":"PubMed","locations":["Thoracic"],"topics":["Diagnosis"],"weight":1,"_version_":1663450393544228864,"score":232.00742},{"pmid":32275978,"title":"The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","text":["The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19.","Chest","Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N","32275978"],"abstract":["With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19."],"journal":"Chest","authors":["Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275978","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.chest.2020.04.003","source":"PubMed","locations":["Thoracic"],"topics":["Diagnosis"],"weight":1,"_version_":1663712077944979457,"score":232.00742},{"pmid":32233064,"title":"Coronavirus pandemic and Colorectal surgery: practical advice based on the Italian experience.","text":["Coronavirus pandemic and Colorectal surgery: practical advice based on the Italian experience.","AIM: The current COVID-19 pandemic is challenging healthcare systems at a global level. We provide a practical strategy to reorganize pathways of emergency and elective colorectal surgery during the COVID-19 pandemic. METHOD: The authors, all from areas affected by the COVID-19 emergency, brainstormed remotely to define the key-points to be discussed. Tasks were assigned, concerning specific aspects of colorectal surgery during the pandemic, including the administrative management of the crisis in Italy. The recommendations (based on experience and on the limited evidence available) were collated and summarized. RESULTS: Little is known about the transmission of COVID-19, but it has shown a rapid spread. It is prudent to stop non-cancer procedures and prioritize urgent cancer treatment. Endoscopy and proctological procedures should be performed highly selectively. When dealing with colorectal emergencies, a conservative approach is advised. Specific procedures should be followed when operating on COVID-19-patients, using dedicated personal protective equipment and adhering to specific rules. Some policies are described, including minimally-invasive surgery. These policies outline the strict regulation of entry/ exit into theatres and operating building as well as advice on performing procedures safely to reduce risk spreading the virus. It is likely that a reorganization of health system is required, both at central and local levels. A description of the strategy adopted in Italy is provided. CONCLUSION: Evidence on the management of patients needing surgery for colorectal conditions during the COVID-19 pandemic is currently lacking. Lessons learnt from healthcare professionals that have managed high volumes of surgical patients during the pandemic could be useful to mitigate some risks and reduce exposure to other patients, public and healthcare staff.","Colorectal Dis","Di Saverio, Salomone","Pata, Francesco","Gallo, Gaetano","Carrano, Francesco","Scorza, Antonella","Sileri, Pierpaolo","Smart, Neil","Spinelli, Antonino","Pellino, Gianluca","32233064"],"abstract":["AIM: The current COVID-19 pandemic is challenging healthcare systems at a global level. We provide a practical strategy to reorganize pathways of emergency and elective colorectal surgery during the COVID-19 pandemic. METHOD: The authors, all from areas affected by the COVID-19 emergency, brainstormed remotely to define the key-points to be discussed. Tasks were assigned, concerning specific aspects of colorectal surgery during the pandemic, including the administrative management of the crisis in Italy. The recommendations (based on experience and on the limited evidence available) were collated and summarized. RESULTS: Little is known about the transmission of COVID-19, but it has shown a rapid spread. It is prudent to stop non-cancer procedures and prioritize urgent cancer treatment. Endoscopy and proctological procedures should be performed highly selectively. When dealing with colorectal emergencies, a conservative approach is advised. Specific procedures should be followed when operating on COVID-19-patients, using dedicated personal protective equipment and adhering to specific rules. Some policies are described, including minimally-invasive surgery. These policies outline the strict regulation of entry/ exit into theatres and operating building as well as advice on performing procedures safely to reduce risk spreading the virus. It is likely that a reorganization of health system is required, both at central and local levels. A description of the strategy adopted in Italy is provided. CONCLUSION: Evidence on the management of patients needing surgery for colorectal conditions during the COVID-19 pandemic is currently lacking. Lessons learnt from healthcare professionals that have managed high volumes of surgical patients during the pandemic could be useful to mitigate some risks and reduce exposure to other patients, public and healthcare staff."],"journal":"Colorectal Dis","authors":["Di Saverio, Salomone","Pata, Francesco","Gallo, Gaetano","Carrano, Francesco","Scorza, Antonella","Sileri, Pierpaolo","Smart, Neil","Spinelli, Antonino","Pellino, Gianluca"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233064","week":"202014|Mar 30 - Apr 05","doi":"10.1111/codi.15056","keywords":["COVID-19","colorectal surgery","complications","emergency","health policy"],"source":"PubMed","locations":["Italy","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663352135398457345,"score":206.2261}]}